Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vertex's Revenue Surges but EPS Slips
Vertex's Revenue Surges but EPS Slips
Vertex's Revenue Surges but EPS Slips
Submitted by
admin
on February 10, 2025 - 10:13pm
Source:
Motley Fool
News Tags:
Vertex Pharmaceuticals
earnings
Headline:
Vertex's Revenue Surges but EPS Slips
snippet:
Revenue surged by 15.6% year over year to $2.91 billion.
Non-GAAP earnings per share of $3.98 missed expectations.
R&D and SG&A expenses rose by 22.9%, impacting operating margins.
Do Not Allow Advertisers to Use My Personal information
